SEC Form 4 · accession 0001209191-19-002792
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven H Stein
Officer — EVP & Chief Medical Officer
Period of report
Jan 4, 2019
Accepted (ET)
Jan 8, 2019 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 7, 2019 | F | 847 | $74.21 | D | 13,773 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $72.27 | Jan 4, 2019 | A | 22,772 | A | — | Jan 3, 2029 | Common Stock | 22,772 | 22,772 | D |
Explanation of responses
- F1Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
- F2Includes an aggregate of 5,416 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F3Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years.